Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).
about
Current adjuvant treatment modalities for gastric cancer: From history to the futureFeeding jejunostomy tube placement during resection of gastric cancers.What make differences in the outcome of adjuvant treatments for resected gastric cancer?Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects.Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach?Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer.Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in re
P2860
Q26748744-D42B4E21-1185-4EE2-8454-132537508090Q37509872-F247ECDE-8EF9-43E7-99CB-283DBEC7EA06Q38247980-AE5938F6-C02C-493E-8B01-585102F32341Q38256334-CD018F82-EDBB-48AD-9F7A-AB08A90CB0DAQ38364619-92B8CD16-4D56-41BB-AE72-A64243FC7CA7Q44125251-F313330A-606C-49D2-83A4-FFD83B922247Q45078946-A0F69C79-A8F3-44DF-A50C-4CFAAEBC98D2Q53181291-5E3C0158-223A-418C-8362-EB0B654571ABQ53239567-786A28C2-0788-4910-A63D-E219273D8099Q53320199-7A30B35A-BF84-4ECC-94C8-CC0EDA77C729Q58755544-6CA2AFD5-4AA7-4DE0-B455-32540A476A18
P2860
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Adjuvant chemotherapy for gast ...... tive D2 gastrectomy (AMC0201).
@en
type
label
Adjuvant chemotherapy for gast ...... tive D2 gastrectomy (AMC0201).
@en
prefLabel
Adjuvant chemotherapy for gast ...... tive D2 gastrectomy (AMC0201).
@en
P2093
P2860
P356
P1476
Adjuvant chemotherapy for gast ...... tive D2 gastrectomy (AMC0201).
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.86
P407
P577
2013-02-28T00:00:00Z